Literature DB >> 23277819

Dexmedetomidine and remifentanil in the perioperative management of an adolescent undergoing resection of pheochromocytoma -A case report-.

Jae-Wook Jung1, Jung Kyu Park, Sang Yoon Jeon, Yong Han Kim, So-Hyun Nam, Young-Gyun Choi, Si Ra Bang.   

Abstract

A 15-year-old adolescent with unilateral multiple adrenal pheochromocytoma had an episode of subcortical intracerebral hemorrhage and seizure 6 weeks before the surgery. He was pretreated with terazosin, losartan, atenolol and levetiracetam for 2 weeks. Dexmedetomidine was started in the preoperative waiting area, and a combination of dexmedetomidine and remifentanil was continuously infused for most of anesthetic time. To control blood pressure, bolus injection of remifentanil and low-dose infusion of sodium nitroprusside, nicardipine, and esmolol were administered during three adrenergic crises. There was minimal post-resection hypotension, and his trachea was extubated safely 20 min after the surgery. He was discharged without noticeable complication. His catecholamine levels showed the steadily decreasing pattern during the operation in this case. Though a combination of dexmedetomidine and remifentanil may not prevent the hemodynamic instability impeccably during the tumor manipulation, this combination seems to be the way of interrupting release of catecholamines and minimizing hemodynamic fluctuations.

Entities:  

Keywords:  Catecholamine; Dexmedetomidine; Pheochromocytoma; Remifentanil

Year:  2012        PMID: 23277819      PMCID: PMC3531537          DOI: 10.4097/kjae.2012.63.6.555

Source DB:  PubMed          Journal:  Korean J Anesthesiol        ISSN: 2005-6419


  14 in total

Review 1.  alpha2-Adrenoceptor agonists: shedding light on neuroprotection?

Authors:  Daqing Ma; Nishanthan Rajakumaraswamy; Mervyn Maze
Journal:  Br Med Bull       Date:  2005-01-31       Impact factor: 4.291

2.  The preoperative management of phaeochromocytoma.

Authors:  W J Russell; I R Metcalfe; A L Tonkin; D B Frewin
Journal:  Anaesth Intensive Care       Date:  1998-04       Impact factor: 1.669

Review 3.  Pheochromocytoma: an approach to antihypertensive management.

Authors:  Emmanuel L Bravo
Journal:  Ann N Y Acad Sci       Date:  2002-09       Impact factor: 5.691

4.  Effects of dexmedetomidine, a selective alpha 2-adrenoceptor agonist, on hemodynamic control mechanisms.

Authors:  A Kallio; M Scheinin; M Koulu; R Ponkilainen; H Ruskoaho; O Viinamäki; H Scheinin
Journal:  Clin Pharmacol Ther       Date:  1989-07       Impact factor: 6.875

5.  Remifentanil for modulation of hemodynamics in a patient undergoing laparoscopic resection of pheochromocytoma.

Authors:  Anis Baraka; Sahar Siddik; Mahmoud Alameddine
Journal:  Middle East J Anaesthesiol       Date:  2004-02

6.  Skin blood flow and plasma catecholamine concentrations during removal of a phaeochromocytoma in a child.

Authors:  H Mikasa; T Sakuragi; K Higa; M Yasumoto
Journal:  Br J Anaesth       Date:  2004-03-05       Impact factor: 9.166

7.  Effects of perioperative alpha1 block on haemodynamic control during laparoscopic surgery for phaeochromocytoma.

Authors:  P Tauzin-Fin; M Sesay; P Gosse; P Ballanger
Journal:  Br J Anaesth       Date:  2004-02-06       Impact factor: 9.166

Review 8.  Dexmedetomidine: sedation, analgesia and beyond.

Authors:  Constantinos Chrysostomou; Carol G Schmitt
Journal:  Expert Opin Drug Metab Toxicol       Date:  2008-05       Impact factor: 4.481

9.  Dexmedetomidine attenuates sympathoadrenal responses to tracheal intubation and reduces the need for thiopentone and peroperative fentanyl.

Authors:  B Scheinin; L Lindgren; T Randell; H Scheinin; M Scheinin
Journal:  Br J Anaesth       Date:  1992-02       Impact factor: 9.166

10.  Effect of remifentanil on the haemodynamic response to orotracheal intubation.

Authors:  J P Thompson; A P Hall; J Russell; B Cagney; D J Rowbotham
Journal:  Br J Anaesth       Date:  1998-04       Impact factor: 9.166

View more
  3 in total

1.  Actualities in the anaesthetic management of pheochromocytoma/ paraganglioma.

Authors:  D Godoroja-Diarto; C Moldovan; V Tomulescu
Journal:  Acta Endocrinol (Buchar)       Date:  2021 Oct-Dec       Impact factor: 1.104

2.  Dexmedetomidine for anaesthetic management of phaeochromocytoma in a child with von Hippel-Lindau type 2 syndrome.

Authors:  Raylene Dias; Nandini Dave; Madhu Garasia
Journal:  Indian J Anaesth       Date:  2015-05

3.  Dexmedetomidine in anaesthesia for a high-risk case of pheochromocytoma with poor left ventricular function.

Authors:  Harihar Vishwanath Hegde; Shivi Maheshwari; B Srinivas Pai; Sameer Ahmed
Journal:  Indian J Anaesth       Date:  2016-02
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.